Minoru Sakamoto

Induction of IFN-λ3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection

Kazumoto Murata, Mai Asano, Akihiro Matsumoto et al. · Gut · 2016 · 190 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features

Fukiko Kawai‐Kitahata, Yasuhiro Asahina, Shinji Tanaka et al. · Journal of Gastroenterology · 2015 · 122 citations

Medicine, Molecular Genetics, Oncology +17

Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors

Masayuki Kurosaki, Yasuhito Tanaka, Nao Nishida et al. · Journal of Hepatology · 2010 · 119 citations

Life Sciences, Immunology, Pharmacology +17

Efficacy and safety of sofosbuvir–velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial

Tetsuo Takehara, Naoya Sakamoto, Shuhei Nishiguchi et al. · Journal of Gastroenterology · 2018 · 118 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Higher prevalence and viral load of TT virus in saliva than in the corresponding serum: Another possible transmission route and replication site of TT virus

Xuewen Deng, Hiroshi Terunuma, Ray Handema et al. · Journal of Medical Virology · 2000 · 81 citations

Life Sciences, Infectious Diseases, Molecular Virology +11